Mahkam Zanganeh has more than 15 years of management, corporate, clinical, and business experience in the pharmaceutical, medical device and technology industries. Most recently, Dr Zanganeh was COO at Pharmacyclics Inc. Under her leadership, the company was able to achieve four FDA labels, with three Breakthrough Therapy Designations, in 14 months; a feat which has never been accomplished by any company before. Dr Zanganeh drove the multimillion dollar collaboration and license deal for ibrutinib with Janssen Biotech Inc in 2011 and the subsequent merger of the company in 2015 with Abbvie Inc.; the second largest biopharma merger ever in the industry ($21bn). Dr Zanganeh currently sits on the Boards of GenoScience, Inc. (Marseille, France), Medable (Palo Alto , CA) and Institute Hospitalo-Universitaire -IHU (Strasbourg, France). Dr Zanganeh was awarded her D.D.S. from the Louis Pasteur University in Strasbourg, France and an MBA from Schiller International University, France. Dr Zanganeh earned the Fierce Biotech " 2013 Top women in biotech"  and Entrepreneur of the year 2013 from E&Y company.   Mahkam Zanganeh has more than 15 years of management, corporate, clinical, and business experience in the pharmaceutical, medical device and technology industries. Most recently, Dr Zanganeh was COO at Pharmacyclics Inc. Under her leadership, the company was able to achieve four FDA labels, with three Breakthrough Therapy Designations, in 14 months; a feat which has never been accomplished by any company before. Dr Zanganeh drove the multimillion dollar collaboration and license deal for ibrutinib with Janssen Biotech Inc in 2011 and the subsequent merger of the company in 2015 with Abbvie Inc.; the second largest biopharma merger ever in the industry ($21bn). Dr Zanganeh currently sits on the Boards of GenoScience, Inc. (Marseille, France), Medable (Palo Alto , CA) and Institute Hospitalo-Universitaire -IHU (Strasbourg, France). Dr Zanganeh was awarded her D.D.S. from the Louis Pasteur University in Strasbourg, France and an MBA from Schiller International University, France. Dr Zanganeh earned the Fierce Biotech " 2013 Top women in biotech"  and Entrepreneur of the year 2013 from E&Y company.  

fermentation